Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era

Hepatology

Volumn 54, Issue 4, 2011, Pages 1313-1321

  Berg, Carl L ^a   Merion, Robert M ^b   Shearon, Tempie H ^b   Olthoff, Kim M ^c   Brown, Robert S ^d   Baker, Talia B ^e   Everson, Gregory T ^f   Hong, Johnny C ^g   Terrault, Norah ^h   Hayashi, Paul H ⁱ   Fisher, Robert A ^j   Everhart, James E ^k  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d University of Pennsylvania ^*  (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; ASCITES; BILE DUCT ATRESIA; BLEEDING; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER GRAFT; LIVING DONOR LIVER TRANSPLANT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MODEL FOR ENDSTAGE LIVER DISEASE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONCHOLESTATIC CIRRHOSIS; OUTCOME ASSESSMENT; PERITONITIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SPONTANEOUS BACTERIAL PERITONITIS; SURVIVAL; VARIX BLEEDING;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 80053330697     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24494     Document Type: Article

References (12)

1. Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JS, et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007; 133: 1806-1813.
2. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. HEPATOLOGY 2001; 33: 1703-1709.
3. Cheng SJ, Pratt DS, Freeman RBJr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001; 72: 861-868.
4. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al. Recurrence of hepatocellular carcinoma and death following living donor and deceased donor liver transplantation in the A2ALL cohort study. Am J Transplant 2007; 7: 1601-1608.
5. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313.
6. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9: 970-981.
7. Kim WR, Thernau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, et al. Deaths on the liver transplant waiting list: an analysis of competing risks. HEPATOLOGY 2006; 43: 345-351.
8. Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4(Suppl 9): 114-131.
9. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, Debroy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
10. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1999-2008: U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; 2010.
11. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
12. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.